We are live on ! Find out more
DC

DPM Capital Portfolio holdings

AUM $78.7M
1-Year Est. Return 2.71%
This Fund
S&P 500
This Quarter Est. Return
-0.15%
1 Year Est. Return
-2.71%
3 Year Est. Return
+109.84%
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
-$54.3M
Cap. Flow
-$54.7M
Cap. Flow %
-46.09%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$7.75M
2
AXTA icon
Axalta
AXTA
+$5.29M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$19.5M
2
WFC icon
Wells Fargo
WFC
+$19.3M
3
PKG icon
Packaging Corp of America
PKG
+$16.2M
4
DAL icon
Delta Air Lines
DAL
+$7.93M
5
SYF icon
Synchrony
SYF
+$4.84M

Sector Composition

Rank Sector Weight
1 Healthcare 72.36%
2 Financials 23.08%
3 Materials 4.56%
4 Consumer Discretionary 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVA icon
1
DaVita
DVA
$15.4B
$78.5M 66.13%
1,375,099
SYF icon
2
Synchrony
SYF
$24.7B
$27.4M 23.08%
803,464
-141,000
-15% -$4.84M
PCRX icon
3
Pacira BioSciences
PCRX
$1.04B
$7.4M 6.23%
+194,262
New +$7.75M
AXTA icon
4
Axalta
AXTA
$7.66B
$5.41M 4.56%
+179,427
New +$5.29M
DAL icon
5
Delta Air Lines
DAL
$57.5B
-139,800
Closed -$7.93M
GS icon
6
Goldman Sachs
GS
$300B
-95,067
Closed -$19.5M
PKG icon
7
Packaging Corp of America
PKG
$21.9B
-170,063
Closed -$16.2M
WFC icon
8
Wells Fargo
WFC
$261B
-408,100
Closed -$19.3M

Similar funds

DPM Capital's Q3 2019 Portfolio in Review

As of Q3 2019, DPM Capital held 8 positions worth $119M, down 31% from $173M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

DPM Capital withdrew a net $54.7M in Q3 2019, closing 4 positions and reducing 1 holding. Its most notable exit was Goldman Sachs, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 45% a quarter earlier, followed by Financials and Materials.

Against the trend, DPM Capital opened a new position in Pacira BioSciences worth $7.4M.

  • DPM Capital's largest Q3 2019 buy was Pacira BioSciences: 194,262 shares worth $7.4M.
  • DPM Capital's biggest Q3 2019 reduction was Synchrony, cutting an estimated $4.84M.
  • DPM Capital fully exited Goldman Sachs in Q3 2019, selling an estimated $19.5M.
  • DPM Capital's ten largest holdings make up 100% of its $119M portfolio in Q3 2019.
  • DPM Capital opened 2 new positions and closed 4 in Q3 2019.
  • DPM Capital's portfolio value fell 31% quarter-over-quarter to $119M.

Based on DPM Capital's 13F filing for Q3 2019, filed 30 Oct 2019.